Cited by 95Gastrointestinal Bleeding Diagnosis and TreatmentPharmacovigilance and Adverse Drug ReactionsAntiplatelet Therapy and Cardiovascular Diseases

Gastro‐intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look

Open access
Opatrny, Lucie, Delaney, J. A. ‘Chris’, Suissa, Samy·2008·British Journal of Clinical Pharmacology

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The known biological effects of selective serotonin reuptake inhibitors (SSRI) on platelets are consistent with an increased risk of gastrointestinal haemorrhage in patients on SSRI therapy. • Previous research supports this increased risk among SSRI users with a large increase in bleeding risk observed. WHAT THIS STUDY ADDS • This large study was able to compare the effects of different classes of antidepressant as well as to test for drug–drug interactions with warfarin. • The discovery of alcohol abuse as a strong confounder may partially explain the very high risks of bleed seen in previous studies that did not adjust for this confounder. AIMS: (i) To determine the effects of selective serotonin reuptake inhibitors (SSRI) and other classes of antidepressants on upper gastro‐intestinal (GI) haemorrhage and (ii) to assess the drug–drug interaction effects of antidepressants and warfarin or clopidogrel on the risk of GI haemorrhage. METHODS: This was a population‐based case control study in the General Practice Research Database (GPRD). Cases with a first episode of upper GI haemorrhage between 2000 and 2005 were matched with up to 10 controls. Exposure to the study drugs was defined by a prescription issued in the 90 days before the index date. Rate ratios were estimated using conditional logistic regression. RESULTS: Four thousand and twenty‐eight cases of GI haemorrhage and 40 171 controls were identified. The excess risk of GI haemorrhage with SSRI use was small (Rate Ratio [RR]: 1.3; 95% confidence interval [CI]: 1.1, 1.6) and null with exposure to tricyclic antidepressants (TCAs) (RR 1.0; 95% CI: 0.8, 1.3). The risk of GI haemorrhage was highest with venlafaxine use (RR: 1.9; 95% CI: 1.3, 2.6). There was no drug–drug interaction between warfarin anticoagulation and antidepressant use. CONCLUSIONS: This study supports a small increased risk of upper GI haemorrhage with the use of SSRI antidepressants compared with the older TCA drugs, but to a lesser extent than previously reported due to confounding by alcohol use. The small elevation in risk of GI haemorrhage with SSRI and venlafaxine should be weighed against the therapeutic benefit of their use.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2008.03154.x

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Dalton S, Johansen C, Mellemkjoer L, Norgard B, Sorensen H, Olsen J. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding. Arch Intern Med 2003; 163: 59-64.

Cited by

Sorted by citations

Authors
Opatrny, L., Delaney, J. A. ‘., & Suissa, S.
Affiliations
  • McGill University Health Centre (CA)
  • McGill University (CA)
Corresponding author
Suissa, Samy
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2008-05-06
Volume
66
Issue
1
Pages
76-81
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W2033887363
Cited by
95
References
27
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2020: 2 · 2019: 4 · 2018: 6 · 2017: 1 · 2016: 3 · 2015: 7 · 2014: 8 · 2013: 7 · 2012: 11
FWCI
13.16
Type
journal article
Language
en
Open access
Locations
  • British Journal of Clinical Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Keywords
gastrointestinal bleeding, selective serotonin reuptake inhibitors, antidepressants, venlafaxine, tricyclic antidepressants, warfarin, clopidogrel, drug-drug interactions, bleeding risk, upper gastrointestinal bleeding, Clinical Practice Research Datalink, case-control study, pharmacoepidemiology
MeSH terms
Clopidogrel, Aged, Aged, 80 and over, Anticoagulants, Antidepressive Agents, Drug Interactions, Female, Gastrointestinal Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk Factors, Ticlopidine, Warfarin, Case-Control Studies, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review